Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
Posted On Thursday, March 13, 2025
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
Posted On Thursday, March 13, 2025
Senti Bio Appoints Feng Hsiung to Board of Directors
Posted On Thursday, March 13, 2025
Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
Posted On Thursday, March 13, 2025
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
Posted On Thursday, March 13, 2025
Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial
Posted On Thursday, March 13, 2025
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
Posted On Thursday, March 13, 2025
FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)
Posted On Thursday, March 13, 2025
Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
Posted On Thursday, March 13, 2025
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
Posted On Thursday, March 13, 2025
NKGen Biotech To Present on Potential of Troculeucel for the Treatment of Neurodegenerative Diseases at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit
Posted On Thursday, March 13, 2025
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
Posted On Thursday, March 13, 2025
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product
Posted On Thursday, March 13, 2025
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Posted On Thursday, March 13, 2025
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Posted On Thursday, March 13, 2025
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
Posted On Thursday, March 13, 2025
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update
Posted On Thursday, March 13, 2025
Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
Posted On Thursday, March 13, 2025
Vanotech Appoints Matthew Schiller to Lead Business Development
Posted On Thursday, March 13, 2025
Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Posted On Thursday, March 13, 2025
ACELYRIN Adopts Limited-Duration Stockholder Rights Plan
Posted On Thursday, March 13, 2025
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Thursday, March 13, 2025
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Posted On Thursday, March 13, 2025
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
Posted On Thursday, March 13, 2025
ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting
Posted On Thursday, March 13, 2025

Print